epicGEN introduces a next-generation technology for precise examination of mutation status in target biomarkers. The technology is based on ultra-deep sequencing of selectively enriched genomic regions, utilizing an optimized hybrid capture system for maximum specificity and sensitivity.
The epicGEN technology is highly precise, ultra-sensitive, specific, and efficient – perfectly suited for clinical diagnostics and translational research, offering new advantages for analyzing complex genetic variations.
New generation of NGS panels
Our epicGEN technology is designed to enable high-efficiency hybrid capture, allowing parallel processing of samples for all targeted genes with maximum specificity and uniform coverage.
epicGEN delivers user-friendly diagnostic NGS kits with exceptional analytical performance and optimized hybrid capture technology, ensuring high precision and efficiency for laboratories of any size.
Five reasons why epicGEN stands out
-
Specific
Highly specific oligonucleotides precisely target desired sequences, minimizing non-specific enrichment and improving coverage.
-
Uniform
Optimized design ensures consistent coverage across target regions, maximizing sequencing efficiency and reliability.
-
Accurate
Minimizes off-target binding, reducing interference from non-coding and repetitive genomic regions for greater precision.
-
Sensitive
Enables reliable enrichment from just less than 1ng of DNA, supporting analysis of challenging samples like cfDNA, FFPE tissues, and rare biological materials.
-
Powerful
Detects somatic mutations at VAF >1% with sufficient sequencing depth (~500×), ensuring high sensitivity in mutation analysis.
Are you interested in more? Contact our product manager.

Iveta Tóthová, PhD.
Product & Scientific Manager+420 724 873 015
tothova@biovendor-mdx.com